Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bibeau

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|October 25, 2006
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1qB Orsetti, M Nugoli, N Cervera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2009
Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature reviewR Le Scodan, F Mornex, N Girard, et al.
The International Journal of Biological Markers|May 23, 2006
Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancerP J Lamy, I Nanni, F Fina, et al.
Diagnostic and Interventional Imaging|April 29, 2014
Utility of reassessment after neoadjuvant therapy and difficulties in interpretationM-A Pierredon-Foulongne, S Nougaret, F Bibeau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2019
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approachC Luchini, F Bibeau, M J L Ligtenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapiesM Del Rio, C Mollevi, F Bibeau, et al.
The Pharmacogenomics Journal|July 21, 2010
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancerA Ho-Pun-Cheung, E Assenat, C Bascoul-Mollevi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2025
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectivesA Marra, S Morganti, F Pareja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical researchC Marchiò, M Scaltriti, M Ladanyi, et al.
British Journal of Cancer|August 20, 2009
Increased expression of class III beta-tubulin in castration-resistant human prostate cancerS Terry, G Ploussard, Y Allory, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|October 25, 2006
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1qB Orsetti, M Nugoli, N Cervera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2009
Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature reviewR Le Scodan, F Mornex, N Girard, et al.
The International Journal of Biological Markers|May 23, 2006
Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancerP J Lamy, I Nanni, F Fina, et al.
Diagnostic and Interventional Imaging|April 29, 2014
Utility of reassessment after neoadjuvant therapy and difficulties in interpretationM-A Pierredon-Foulongne, S Nougaret, F Bibeau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2019
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approachC Luchini, F Bibeau, M J L Ligtenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapiesM Del Rio, C Mollevi, F Bibeau, et al.
The Pharmacogenomics Journal|July 21, 2010
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancerA Ho-Pun-Cheung, E Assenat, C Bascoul-Mollevi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2025
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectivesA Marra, S Morganti, F Pareja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical researchC Marchiò, M Scaltriti, M Ladanyi, et al.
British Journal of Cancer|August 20, 2009
Increased expression of class III beta-tubulin in castration-resistant human prostate cancerS Terry, G Ploussard, Y Allory, et al.
Pageof 5